Tapentadol Prolonged Release for Severe Chronic Osteoarthritis Pain in the Elderly-A Subgroup Analysis of Routine Clinical Practice Data.

Conclusion: Tapentadol PR provided effective and well-tolerated treatment of severe chronic OA pain for elderly patients in routine clinical practice. The favorable tolerability profile in particular suggests tapentadol PR as a treatment option before classical strong opioids are considered. PMID: 32351639 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32351639?dopt=Abstract

Source: Pain Research and Management - May 1, 2020 Category: Anesthesiology Authors: Schwittay A, Sohns M, Heckes B, Elling C Tags: Pain Res Manag Source Type: research